1 finantziazioak - 58.073€

2021az geroztik eskuragarri dauden datuak

2021

  1. Reduction of inflammatory responses against adenoviral vectors to improve safety and efficacy of gene therapy for Dravet syndrome (RIRADS)

    euro 58.073,00